Ds2 - Effectiveness and Safety of Standard and Reduced Doses of Dabigatran Versus Rivaroxaban in Non-Valvular Atrial Fibrillation: A Cohort Study in the SNDS French Nationwide Claims Database
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.043
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV